Lipoprotein-associated phospholipase A <sub>2</sub> (Lp-PLA <sub>2</sub> ) as a therapeutic target to prevent retinal vasopermeability during diabetesPaul Canning, Alan W. Stitt, Vivien E. Prise et al.|Proceedings of the National Academy of Sciences|2016Cited by 69